Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 24: 657-662, 1978;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kabra, P. M.
Right arrow Articles by Marton, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kabra, P. M.
Right arrow Articles by Marton, L. J.

Clinical Chemistry, Vol 24, 657-662, Copyright © 1978 by American Association for Clinical Chemistry

Simultaneous liquid-chromatographic determination of 12 common sedatives and hypnotics in serum

PM Kabra, HY Koo and LJ Marton

We present a method for simultaneously determining 12 hypnotics and sedatives (primidone, methyprylon, phenobarbital, butabarbital, butalbital, ethchlorvynol, pentobarbital, amobarbital, phenytoin, glutethimide, secobarbital and methaqualone) in 200 microliter of serum. Serum proteins are precipitated with an acetonitrile solution containing 5-(4-methylphenyl)-5-phenylhydantoin, the internal standard. The drugs are eluted from a reversed-phase column with a mobile phase consisting of an acetonitrile/phosphate buffer, at a flow rate of 3.0 ml/min. The eluted drugs are detected by their absorption at 195 nm; their quantities are estimated from their peak heights. Each analysis requires no longer than 30 min at the optimum column temperature of 50 degrees C. The lower limit of detection for all of these drugs is less than 10 ng/sample for drug standard. A sensitivity of 1.0 mg/liter of serum is attained routinely for each of the drugs. Analytical recoveries for the 12 drugs varied from 94 to 112%, with good day-to- day precision (CV between 3.8 and 10.4%). Of more than 35 drugs tested for possible interference, only ethotoin interferes with the analysis of phenobarbital.


The following articles in journals at HighWire Press have cited this article:


Home page
 Arch Gen PsychiatryHome page
M. A. Raskind, E. R. Peskind, R. C. Veith, S. C. Risse, T. H. Lampe, S. Borson, G. Gumbrecht, and D. M. Dorsa
Neuroendocrine Responses to Physostigmine in Alzheimer's Disease
Arch Gen Psychiatry, June 1, 1989; 46(6): 535 - 540.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
J. A. Sanfield, O. A. Linares, D. D. Cahalan, J. M. Forrester, J. B. Halter, and S. G. Rosen
Altered Norepinephrine Metabolism in Shapiro's Syndrome
Arch Neurol, January 1, 1989; 46(1): 53 - 57.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
M. A. Raskind, E. R. Peskind, J. B. Halter, and D. C. Jimerson
Norepinephrine and MHPG Levels in CSF and Plasma in Alzheimer's Disease
Arch Gen Psychiatry, April 1, 1984; 41(4): 343 - 346.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
E. W. Reimold
Changes in Zinc Metabolism During the Course of the Nephrotic Syndrome
Arch Pediatr Adolesc Med, January 1, 1980; 134(1): 46 - 50.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American Association for Clinical Chemistry.